Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
2004
Purpose: Multiple myeloma is a malignant plasma cell disorder accounting for about 10% of hematological malignancies. Despite treatment advances, including hematopoietic stem-cell transplantation to facilitate administration of high-dose cytotoxic chemotherapy, the median survival remains
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
48
References
287
Citations
NaN
KQI